《大行報告》野村上調中興(00763.HK)目標價至32元 評級「買入」
野村發表報告,指中興(00763.HK)第三季業績強勁,收入和純利分別按年增長14%和108%,預計健康的增長勢頭將在第四季持續,維持「買入」評級,上調目標價由30元至32元。
野村將中興2021年至2023年的收入和盈利預測分別略微提高0至2%,以及2%至4%,以反映業務擴張和利潤率的良好前景。
野村引述中興通訊在上季稱,由於5G網絡的需求恢復,公司的核心電信設備業務在下半年將加速發展。該行預計有關趨勢將在第四季持續,並支持利潤率。
另外,除了現有的增長動力,中興通訊正在尋求在其他領域拓展業務領域,如汽車電子、企業數字化。而公司近期與一汽和上汽簽署合作協議,該行期待在未來幾年有更多的成果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.